Socioeconomic Factors and Mortality in the Intensive Care Population

November 17, 2024 updated by: Anna Aronsson, Uppsala University

Impact of Comorbidity on the Association Between Socioeconomic Factors and Long-term Mortality of Intensive Care Patients

It is important to find out how much of the socioeconomic factors´ impact on mortality on ICU patient´s can be explained by the presence of comorbidity. The aim of this study is to clarify the impact of socioeconomic factors on mortality and how much of this effect are due to comorbidity in the intensive care population.

Study Overview

Status

Completed

Conditions

Detailed Description

The first ICU admissions of patients aged 30 years and older, registered in the Swedish Intensive Care Registry (SIR) from 2009 to 2012 were included. SIR was linked to the National Patient Register, Statistics Sweden and the Cause of Death Register using unique person identity numbers. Educational level and disposable income was reported in the year preceding the admission to intensive care to not be affected by the current illness.

Study Type

Observational

Enrollment (Actual)

101745

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The first ICU admissions of patients aged 30 years and older, registered in the Swedish Intensive Care Registry (SIR) from 2009 to 2012.

Description

Inclusion Criteria:

  • Registered in the Swedish Intensive Care Registry (SIR) from 2009 to 2012.
  • The first ICU admission
  • Patients aged 30 years and older

Exclusion Criteria:

  • Missing registration of educational level
  • Missing registration of income

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Income
  1. 0-9999 Euros
  2. 10 000-29 999 Euros
  3. 30 000-49 999 Euros
  4. > 50 000 Euros
Educational level
  1. Low - compulsory school (9 years)
  2. Medium - upper secondary school (additional 2-4 years)
  3. High - included education beyond that level (university)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality
Time Frame: january 1, 2009 til december 31, 2016
Mortality
january 1, 2009 til december 31, 2016

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Uppsala University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2009

Primary Completion (Actual)

December 31, 2016

Study Completion (Actual)

December 31, 2016

Study Registration Dates

First Submitted

August 12, 2024

First Submitted That Met QC Criteria

August 12, 2024

First Posted (Actual)

August 15, 2024

Study Record Updates

Last Update Posted (Estimated)

November 20, 2024

Last Update Submitted That Met QC Criteria

November 17, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • UU Intensive Care

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

It is a register-based study where all the data are deidentified.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Comorbidity

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe